NIMI
MD icon

Natixis Investment Managers International’s Pediatrix Medical MD Stock Holding History

Natixis Investment Managers International’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-3,519
Closed -$152K – 283
2017
Q3 		$152K Buy
+3,519
New +$167K 0.01% 334
2016
Q3 		– Sell
-10,978
Closed -$795K – 383
2016
Q2 		$795K Buy
+10,978
New +$755K 0.09% 153

Other funds holding MD

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BHG
Blue Harbour Group Greenwich, Connecticut $353M AUM 8.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

Natixis Investment Managers International's MD Position: Q4 2017 in Review

Natixis Investment Managers International sold out of Pediatrix Medical (MD) in Q4 2017, closing a stake of 3,519 shares — an estimated $152K sold.

Natixis Investment Managers International first reported a position in MD in Q2 2016 and held it in 2 quarters. The position peaked at $795K in Q2 2016. 330 funds tracked by Wall St. Rank hold MD as of Q4 2017.

  • Natixis Investment Managers International reported no remaining Pediatrix Medical position as of Q4 2017 after selling out during the quarter.
  • Natixis Investment Managers International sold 3,519 Pediatrix Medical shares in Q4 2017, an estimated $152K.
  • Natixis Investment Managers International first reported a position in Pediatrix Medical in Q2 2016 and held it in 2 quarters.
  • Natixis Investment Managers International's Pediatrix Medical position peaked at $795K in Q2 2016.
  • 330 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2017.

Based on Natixis Investment Managers International's 13F filing for Q4 2017, filed 14 Feb 2018.